GlassScriptPhysician profile
Todd L Hicks
NPI 1326054073
$15,459.15
in general payments reported to CMS, 2019-2025
17 companies · $4,107 in 2025
The $4,107 reported for 2025 was more than what 90% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $67.20 · 2021: $50.29 · 2022: $19.25 · 2023: $80.83 · 2024: $29.54 · 2025: $4,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $871 · Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $870.94 |
| Food and Beverage | $346.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $10,852.00 | 2019 | |
| Polynovo North America LLC | $4,040.94 | 2023-2025 | Novosorb Btm |
| Kci USA, INC. | $122.30 | 2019 | |
| Medline Industries LP | $103.49 | 2019 | |
| Sientra, INC. | $84.94 | 2020-2021 | |
| Solventum Corporation | $65.63 | 2024-2025 | Prevena Restor Bellaform, V.A.C. Veraflo, Prevena |
| Baxter Healthcare | $35.75 | 2023-2025 | Artiss |
| Smith+Nephew, INC. | $30.83 | 2025 | Stravix |
| Allergan, INC. | $22.76 | 2020 | |
| Covidien LP | $18.81 | 2019 | |
| Abbvie INC. | $15.31 | 2025 | |
| Urgo Medical North America, LLC | $14.65 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Galderma Laboratories, L.P. | $14.33 | 2023 | Dysport |
| Integra Lifesciences Corporation | $12.45 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $9.79 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polarityte, INC. | $8.37 | 2019 | |
| Kerecis Limited | $6.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.